All posts by GTCbio


Regulatory Considerations to Bring Antibody Therapies to Market

GTCbio | May 9th, 2017

As novel Antibody and Protein-based therapies are showing clinical promise in human trials, the field will require new measures of coordination with regulatory agencies to ensure these new therapeutic approaches are brought safely and in a timely fashion to market. Although, there is high interest in expediting Antibody and Protein-based therapies, the regulatory approval is…read more